Our medical system is broken. Patients are struggling to keep up with expensive treatment options and looking for an alternative. The CRISPR gene-editing method could be this alternative.
It's time to get very excited about gold again. 2018 is going to be a breakout year for the yellow metal. Energy and Capital editor Luke Burgess shows you how to get started investing today.
Emerging markets are becoming more valuable... particularly China. Energy and Capital editor Christian DeHaemer tells you why you must buy this company now.
Energy and Capital editor Keith Kohl talks West Texas oil and why the Permian Basin is going to be the most important oil region for investors in 2018.
Energy and Capital editor Christian DeHaemer goes all in on the EV market in China. Here's why it's outpacing U.S. automakers in the EV rush.
Tesla’s king, but there’s another player making a race for the ultimate electric car stock. Energy & Capital editor Jeff Siegel discusses an overlooked opportunity in electric vehicles...
This groundbreaking gene-editing method could disrupt the trillion-dollar treatment industry that plagues most Americans, eliminating diseases like cancer, HIV, and Alzheimer's for good.
Energy and Capital editor Keith Kohl shows investors the best way to capitalize on the EV revolution taking place today.
How protectionist policies issued by the Trump administration will affect investors, consumers, and the economy.
This is the worst chart on the internet. It stinks. It’s a worthless economic cliché. Actually, it's the constantly recurring Shiller P/E (CAPE) ratio chart.
Energy and Capital editor Keith Kohl shows readers how to carve off their own piece of the EV revolution in 2018.
Energy and Capital editor Jeff Siegel talks about cannabis market gains and why Innovative Industrial Properties (NYSE: IIPR) is a buy.
ENERGY AND CAPITAL
3 EAST READ ST
BALTIMORE, MD 21202
TEL: (877) 303-4529
FAX: (410) 814-5959
© ENERGY AND CAPITAL. ALL RIGHTS RESERVED.
